Format

Send to

Choose Destination
See comment in PubMed Commons below
Exp Gerontol. 2007 Jun;42(6):538-44. Epub 2007 Jan 30.

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.

Author information

1
Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Sciences at North Bristol, University of Bristol, Frenchay Hospital, Frenchay, Bristol, United Kingdom. Doris.Culpan@bristol.ac.uk

Abstract

The levels of pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha), are increased in the brain in Alzheimer's disease (AD). Most of the biological properties of TNF-alpha are mediated through its two receptors, tumour necrosis factor receptors I and II (TNF-RI and TNF-RII). We have used immunohistochemistry, Western blotting and real time-PCR (RT-PCR) on frontal (BA 6/24) and temporal (BA 20-22) neocortex and hippocampus from AD and control brains to determine if both receptor proteins were present and expressed in AD and if sequence variations (SNPs) in the promoter regions of the two genes are associated with AD. Expression of TNF-RI exceeded that of TNF-RII in AD and control brains at protein and mRNA levels. The level of TNF-RI protein varied considerably in individual brains but not between AD and control brains. None of the identified TNF-RI and -RII SNPs in the promoter regions of the genes was linked with AD. Our findings suggest that TNF-RI and -RII promoter gene polymorphisms and variations in protein and gene expression of these receptors are unlikely to play a major role in the development of AD.

PMID:
17267158
DOI:
10.1016/j.exger.2006.12.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center